Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MREAC to Review MR Certification, Accreditation Systems
November 7, 2005
- BUSINESS NEWS IN BRIEF
November 7, 2005
- Korosho's Healthcare Reform Proposals Criticized by Prefectural Governor
November 7, 2005
- REGULATORY NEWS IN BRIEF
November 7, 2005
- the 6th Kitasato University-Harvard School of Public Health Symposium
November 7, 2005
- Japan Lags Behind Other Countries in Terms of Access to New Drugs: OPIR Report
November 7, 2005
- Strengthen Consultation System to Promote Participation in Int'l Clinical Trials: Dr Doi of PMDA
November 7, 2005
- Requirements Relaxed to Facilitate IITs
November 7, 2005
- Korosho to Fund Research Projects to Improve Clinical Research Infrastructure
November 7, 2005
- JMA Pamphlet Questions Need to Control Healthcare Spending
November 7, 2005
- R&D NEWS IN BRIEF
November 7, 2005
- SURVEY 2 articles
November 7, 2005
- IC Tag Commercialization Research Project Invites Members
November 7, 2005
- SymBio to Address "Underserved Therapeutic Areas"
November 7, 2005
- NEW PRODUCTS
November 7, 2005
- Drug Companies to Enjoy Good Results in 1st Half
November 7, 2005
- SEMINAR
November 7, 2005
- Eisai Licenses Vaccine Adjuvant to Sanofi Pasteur
November 7, 2005
- Kyorin Licenses OAB Treatment to LG Life Sciences of South Korea
November 7, 2005
- MOF, Korosho, JMA Debate Korosho's Healthcare Reform Proposals
October 31, 2005
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…